Efficacy of oral vancomycin in primary prevention of Clostridium Difficile infection in elderly patients treated with systemic antibiotic therapy

被引：12

作者：

Papic, Neven ^{[1
]}

Maric, Lorna Stemberger ^{[1
,2
]}

Vince, Adriana ^{[1
,3
]}

机构：

[1] Univ Hosp Infect Dis, Zagreb, Croatia

[2] Univ Zagreb, Sch Dent Med, Zagreb, Croatia

[3] Univ Zagreb, Sch Med, Zagreb, Croatia

来源：

INFECTIOUS DISEASES | 2018年 / 50卷 / 06期

关键词：

RESISTANT ENTEROCOCCI; METRONIDAZOLE; EPIDEMIOLOGY; DISEASE; ADULTS;

D O I：

10.1080/23744235.2018.1425551

中图分类号：

R51 [传染病];

学科分类号：

100401 ;

摘要：

引用

页码：483 / 486

页数：4

共 50 条

[11] Effectiveness of Oral Vancomycin for Prevention of Healthcare Facility-Onset Clostridioides difficile Infection in Targeted Patients During Systemic Antibiotic Exposure [J].

Johnson, Steven W. ;

Brown, Shannon, V ;

Priest, David H. .

CLINICAL INFECTIOUS DISEASES, 2020, 71 (05) :1133-1139

[12] A Real-World Evaluation of Oral Vancomycin for Severe Clostridium difficile Infection: Implications for Antibiotic Stewardship Programs [J].

Le, Frank ;

Arora, Vaneet ;

Shah, Dhara N. ;

Salazar, Miguel ;

Palmer, Hannah R. ;

Garey, Kevin W. .

PHARMACOTHERAPY, 2012, 32 (02) :129-134

[13] The effect of concomitant use of systemic antibiotics in patients with Clostridium difficile infection receiving metronidazole therapy [J].

Jin, S. J. ;

Seo, K. H. ;

Wi, Y. M. .

EPIDEMIOLOGY AND INFECTION, 2018, 146 (05) :558-564

[14] Comparison of treatment outcomes with vancomycin alone versus combination therapy in severe Clostridium difficile infection [J].

Bass, S. N. ;

Bauer, S. R. ;

Neuner, E. A. ;

Lam, S. W. .

JOURNAL OF HOSPITAL INFECTION, 2013, 85 (01) :22-27

[15] Vaccines in development for the primary prevention of Clostridium difficile infection [J].

Legenza, Laurel M. ;

Barnett, Susanne G. ;

Rose, Warren E. .

JOURNAL OF THE AMERICAN PHARMACISTS ASSOCIATION, 2017, 57 (04) :547-549

[16] Fidaxomicin versus oral vancomycin for severe Clostridium difficile infection: a retrospective cohort study [J].

Gentry, C. A. ;

Nguyen, P. K. ;

Thind, S. ;

Kurdgelashvili, G. ;

Skrepnek, G. H. ;

Williams, R. J., II .

CLINICAL MICROBIOLOGY AND INFECTION, 2019, 25 (08) :987-993

[17] The Addition of Intravenous Metronidazole to Oral Vancomycin is Associated With Improved Mortality in Critically Ill Patients With Clostridium difficile Infection [J].

Rokas, Kristina E. E. ;

Johnson, James W. ;

Beardsley, James R. ;

Ohl, Christopher A. ;

Luther, Vera P. ;

Williamson, John C. .

CLINICAL INFECTIOUS DISEASES, 2015, 61 (06) :934-941

[18] Oral teicoplanin versus oral vancomycin for the treatment of severe Clostridium difficile infection: a prospective observational study [J].

Popovic, Natasa ;

Korac, Milos ;

Nesic, Zorica ;

Milosevic, Branko ;

Urosevic, Aleksandar ;

Jevtovic, Djordje ;

Mitrovic, Nikola ;

Markovic, Aleksandar ;

Jordovic, Jelena ;

Katanic, Natasa ;

Barac, Aleksandra ;

Milosevic, Ivana .

EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES, 2018, 37 (04) :745-754

[19] Oral vancomycin may have significant absorption in patients with Clostridium difficile colitis [J].

Chihara, Shingo ;

Shimizu, Riha ;

Furukata, Satoshi ;

Hoshino, Koichi .

SCANDINAVIAN JOURNAL OF INFECTIOUS DISEASES, 2011, 43 (02) :149-150

[20] Clostridium difficile treatment in neutropenic patients: Clinical outcomes of metronidazole, vancomycin, combinations, and switch therapy [J].

Tieu, Jennifer D. ;

Schmidt, Sarah A. ;

Miller, Jamie L. ;

Kupiec, Katherine E. ;

Skrepnek, Grant H. ;

Liu, Connie ;

Smith, Winter J. .

JOURNAL OF ONCOLOGY PHARMACY PRACTICE, 2019, 25 (03) :520-528

← 1 2 3 4 5 →